Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

BUY
$229.03 - $291.01 $183,224 - $232,808
800 New
800 $0
Q4 2020

Feb 03, 2021

SELL
$216.38 - $257.67 $173,104 - $206,136
-800 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$234.65 - $260.95 $187,720 - $208,760
800 New
800 $203,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Investment Management Of Virginia LLC Portfolio

Follow Investment Management Of Virginia LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Management Of Virginia LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment Management Of Virginia LLC with notifications on news.